Press releaseBusiness Wire
Coya Therapeutics
COYA · NASDAQ
$4.21+$0.01 (+0.24%)TodayMarket closed ·
Prev close $4.20
About COYA
- Employees
- 8
- Headquarters
- Houston, Texas
- Listed
- Dec 29, 2022
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- coyatherapeutics.com
COYA key statistics
- Market cap
- 98.76M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 142.84K
- Volume
- 82.92K
- Open price
- $4.22
- High today
- $4.38
- Low today
- $4.21
- 52 Week high
- $7.55
- 52 Week low
- $3.71
Coya Therapeutics (COYA) at a glance
As of Oct 20, 2026, Coya Therapeutics (COYA) shares are priced at $4.21, giving the company a market cap of 98.76M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $4.21 and $4.38. The current price is 0.0% above the day's low and 3.9% below its high.
Volume so far is 82.92K shares, below the average of 142.84K shares a day.
Over the past year Coya Therapeutics has ranged from $3.71 to $7.55, and now sits 13% of the way up that range.
Coya Therapeutics met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported -$0.28 per share against an estimate of -$0.3468.
The average analyst price target is $15.47, 267.5% above the current price, from 5 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
100%of 5 analyst ratings say Buy
- Buy100.0%
- Hold0.0%
- Sell0.0%
Price target · 8 analystsAvg $15.47
- Low
- $12.12
- Now
- $4.21
- High
- $18.90
COYA earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 30.4% on average.
- Q3 FY24: reported -$0.26 per share against an estimate of -$0.4233
- Q4 FY24: reported -$0.17 per share against an estimate of -$0.2703
- Q1 FY25: reported -$0.44 per share against an estimate of -$0.1989
- Q2 FY25: reported -$0.36 per share against an estimate of -$0.4007
- Q3 FY25: reported -$0.13 per share against an estimate of -$0.2788
- Q4 FY25: reported -$0.34 per share against an estimate of -$0.2783
- Q1 FY26: reported -$0.32 per share against an estimate of -$0.4216
- Q2 FY26: reported -$0.28 per share against an estimate of -$0.3468
COYA news
- Press releaseBusiness Wire
Coya Therapeutics Announces Participation at Chardan's 10th Annual Healthcare Conference
- Press releaseBusiness Wire
Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
- Press releaseBusiness Wire
Coya Therapeutics Announces Enrollment of 100th Participant in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
- Press releaseBusiness Wire
Coya Therapeutics Announces Publication of Preclinical Study Demonstrating Combination Immunomodulatory Effects of COYA 303 in a Well-Established Model of Peripheral and CNS Inflammation
- Press releaseBusiness Wire
Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting
- Press releaseBusiness Wire
Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
- Press releaseBusiness Wire
Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase
Similar companies
Companies in the same industry as Coya Therapeutics
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.